KP Biosciences
Orem, US · Founded 2015 · Delaware corporation
Founders & leadership
MH
Marc HansenExecutive
ME
Mark ElderExecutive
MC
Matthew CryerExecutive
KL
Kyle LaneExecutive
Board
SS
Steve SmithBoard director
Reported raises · per SEC filings
Form D private placements$330K disclosed across 2 rounds · 2016–2018
▶$50KraisedJan 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$50KraisedJan 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Marc HansenExecutive Officer
- Steve SmithDirector
- Mark ElderExecutive Officer
- Matthew CryerExecutive Officer, Director
- Kyle LaneExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $50K
- Minimum investment
- $50K
- Proceeds to insiders
- $77.5K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$280KraisedFeb 2017 · 3 investors · PharmaceuticalsRule 506(b)
▶$280KraisedFeb 2017 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kyle LaneExecutive Officer, Director
- Matthew CryerExecutive Officer, Director
- Steve SmithDirector
- Robert AllenDirector
- Offering amount
- $1.2M
- Amount sold
- $280K
- Minimum investment
- $50K
- Proceeds to insiders
- $77.5K
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has KP Biosciences raised?
- KP Biosciences has disclosed $330K raised across 2 rounds.
- Where is KP Biosciences headquartered?
- KP Biosciences is headquartered in Orem, US.